Sandvig-Pharma ApS: Financial statements 2026
CVR: 40667687
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
Sandvig-Pharma ApS (CVR 40667687) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK -3,124,962 and a net result of DKK -2,653,774 compared with DKK -3,988,029 the year before. Equity in the 2026 report amounted to DKK -20,495,674.
- Gross Profit
- DKK -3,124,962
- Profit/Loss
- DKK -2,653,774
- Equity
- DKK -20,495,674
- Total Assets
- DKK 7,804,715
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | -3.1M | -2.7M | -20.5M | - |
| 2025 | - | -4.5M | -4M | -17.8M | 2 |
| 2024 | - | -3.3M | -5.6M | -13.9M | 1 |
| 2023 | - | -1.2M | -7.8M | -8.3M | - |
| 2022 | - | -423K | -573K | -523K | - |
Official annual report
Find more companies like Sandvig-Pharma ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2026
Contact info changed: new phone: 30580398, new email: [email protected] (August 14, 2026).
About Sandvig-Pharma ApS
Sandvig-Pharma ApS is a Danish company of the type Anpartsselskab based in Aabenraa, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Z-Pharma ApS and Zibo Pharma ApS. The management consists of Lars Buchard Denker. The company is owned by Sandvig Capital ApS. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK -3,124,962 and a net result of DKK -2,653,774 compared with DKK -3,988,029 the year before. Equity in the 2026 report amounted to DKK -20,495,674.